Bradford Whitmore Buys 28,588 Shares of Ultralife (NASDAQ:ULBI) Stock

Ultralife Corporation (NASDAQ:ULBI) Director Bradford Whitmore acquired 28,588 shares of the business’s stock in a transaction dated Tuesday, December 16th. The stock was acquired at an average price of $5.70 per share, with a total value of $162,951.60. Following the completion of the transaction, the director directly owned 1,235,631 shares of the company’s stock, valued at approximately $7,043,096.70. This represents a 2.37% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Ultralife Price Performance

ULBI traded up $0.04 during midday trading on Tuesday, hitting $5.79. 75,026 shares of the company traded hands, compared to its average volume of 70,149. The business has a 50 day simple moving average of $6.19 and a two-hundred day simple moving average of $7.11. Ultralife Corporation has a 52-week low of $4.07 and a 52-week high of $9.52. The company has a market capitalization of $96.40 million, a price-to-earnings ratio of 57.90 and a beta of 0.88. The company has a current ratio of 2.99, a quick ratio of 1.42 and a debt-to-equity ratio of 0.34.

Ultralife (NASDAQ:ULBI) last posted its quarterly earnings data on Monday, November 17th. The technology company reported ($0.07) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.21 by ($0.28). Ultralife had a return on equity of 1.66% and a net margin of 0.92%.The firm had revenue of $43.37 million during the quarter, compared to analyst estimates of $53.00 million.

Institutional Trading of Ultralife

Institutional investors and hedge funds have recently bought and sold shares of the business. Lazard Asset Management LLC increased its holdings in shares of Ultralife by 1,650.0% in the 2nd quarter. Lazard Asset Management LLC now owns 5,565 shares of the technology company’s stock valued at $49,000 after acquiring an additional 5,247 shares during the last quarter. Prelude Capital Management LLC acquired a new position in Ultralife in the third quarter valued at approximately $71,000. Jones Financial Companies Lllp increased its stake in Ultralife by 1,428.7% in the first quarter. Jones Financial Companies Lllp now owns 15,287 shares of the technology company’s stock valued at $82,000 after purchasing an additional 14,287 shares during the last quarter. Bank of America Corp DE raised its holdings in Ultralife by 30.7% during the fourth quarter. Bank of America Corp DE now owns 12,067 shares of the technology company’s stock worth $90,000 after purchasing an additional 2,836 shares in the last quarter. Finally, Squarepoint Ops LLC purchased a new stake in shares of Ultralife during the 3rd quarter worth approximately $109,000. 30.68% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

ULBI has been the subject of several analyst reports. Wall Street Zen cut shares of Ultralife from a “strong-buy” rating to a “hold” rating in a research note on Saturday, September 13th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Ultralife in a report on Monday. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, Ultralife presently has an average rating of “Sell”.

Ultralife Company Profile

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.